This is apparent in the group’s latest FY2022 ended Dec 31, 2022, results, which saw revenue growing by 10.3% y-o-y to $87.6 million, while profits gained 5.3% y-o-y to $9.0 million. Total dividend were at 2.2 cents, higher than 2.0 cents a year ago, representing a favourable 6.6% dividend yield based on the current share price.

Chan views the group’s ex-cash P/E of 5.2 times and FY2022 return on equity (ROE) of 15.7% as attractive. He has also kept his ‘buy’ call and 48 cents target price on the counter.

In Chan’s opinion, the outlook for Choo Chiang remains positive for the year ahead, driven by strong demand from customers and project sales. Despite raw material price pressures and an inflationary environment, margins have also remained stable.

The group is also shielded from interest-rate hikes as it does not have any interest-bearing debt. A portion of its $23.3 million cash pile is invested in fixed deposits which can provide additional interest income in FY2023.

“A potential divestment of its non-core investment properties can also be reinvested into the higher-yielding distribution business and act as a share price catalyst,” says Chan.

<span class='see_also_inread'><b>See also: <a class='gtm_see_also_1_inread' style='text-decoration: underline;' href='/capital/brokers-calls/rhb-upbeat-raffles-medicals-contract-win-providing-medical-services?utm_source=website&utm_medium=article&utm_campaign=ONPAGESEO'>RHB ‘upbeat’ on Raffles Medical’s contract win for providing medical services at Connect@Changi</a></b></span>

As at 3.30pm, shares in Choo Chiang are trading flat at 30 cents.

Choo Chiang rides the construction boom

VTAC proposes business combination with live streaming platform 17LIVE

Data is the new oil but is it as dirty?

'Transition credits' could sweeten deal for early retirement of coal-fired power plants: MAS, McKinsey paper

DPM Lawrence Wong appointed as GIC’s deputy chairman

Will the Rising Sun keep rising?

Trade Stocks, ETFs, Forex and Futures with Phillip Nova:

RHB ‘upbeat’ on Raffles Medical’s contract win for providing medical services at Connect@Changi

Redevelopment of Marina Square ‘decent RNAV accretion’ of 4% to 6% for UOL, says Citi

Citi ups TP while DBS keeps 'buy' call on Singtel following long-awaited divestment of loss-making Trustwave

Choo Chiang rides the construction boom

Related News

Highlights

VTAC proposes business combination with live streaming platform 17LIVE

Related News

Analysts upbeat on Singtel's outlook as it unlocks more value with latest divestment

BRC Asia steels for recovery, eyes region for further growth

Golden Agri lowers earnings estimates after lower FFB output assumptions; 1HFY2023 earnings ‘largely in line'